Intuitive Surgical (ISRG) Research & Development (2009 - 2026)

Intuitive Surgical's Research & Development history runs 18 years deep, the most recent figure standing at $370.6 million for Q2 2026.

• On a quarterly basis, Research & Development rose 18.29% year-over-year to $370.6 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 16.91% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 14.54% from the prior year.
• Research & Development grew to $370.6 million in Q2 2026 per ISRG's latest filing, from $361.9 million in the prior quarter.
• Across five years, Research & Development topped out at $370.6 million in Q2 2026 and bottomed at $207.3 million in Q2 2022.
• The 5-year median for Research & Development is $282.3 million (2024), against an average of $281.5 million.
• Across the five-year window, Research & Development soared 33.1% in 2022 and advanced 6.55% in 2023, its largest moves.
• Year by year, Research & Development stood at $244.1 million in 2022, then gained by 6.55% to $260.1 million in 2023, then advanced by 13.3% to $294.7 million in 2024, then increased by 19.75% to $352.9 million in 2025, then advanced by 5.02% to $370.6 million in 2026.
• Per Business Quant, the three latest ISRG Research & Development figures stand at $370.6 million (Q2 2026), $361.9 million (Q1 2026), and $352.9 million (Q4 2025).